Roth Capital Initiates Coverage Of GenVec

Roth Capital initiated coverage of GenVec Inc. (Nasdaq: GNVC) with a Buy rating and set a price target of $4 on the stock lifting the stock price 27 cents to close at $1.71.

Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.